Electrospun polyurethane/Eudragit® L100-55 composite mats for the pH dependent release of paclitaxel on duodenal stent cover application

International Journal of Pharmaceutics

Volumn 478, Issue 1, 2015, Pages 1-8

  Aguilar, Ludwig Erik ^a   Unnithan, Afeesh Rajan ^a   Amarjargal, Altangerel ^a,b   Tiwari, Arjun Prasad ^a   Hong, Seong Tshool ^a   Park, Chan Hee ^a   Kim, Cheol Sang ^a  

^a Chonbuk National University   (South Korea)

^b MONGOLIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Mongolia)

Author keywords

Drug eluting stent; Electrospinning; Eudragit; Nanofiber; pH sensitive polymers

Indexed keywords

CHOLECYSTOKININ OCTAPEPTIDE; EUDRAGIT; NANOCOMPOSITE; NANOFIBER; PACLITAXEL; POLYURETHAN; ANTINEOPLASTIC AGENT; METHYLMETHACRYLATE-METHACRYLIC ACID COPOLYMER; POLYMETHACRYLIC ACID DERIVATIVE;

ARTICLE; BIOCOMPATIBILITY; BIOMECHANICS; CELL PROLIFERATION; CELL VIABILITY; CONDUCTANCE; CONTROLLED STUDY; DIFFERENTIAL SCANNING CALORIMETRY; DRUG DECOMPOSITION; DRUG ELUTING DIGESTIVE STENT; DUODENUM; DUODENUM STENT; ELECTROSPINNING; FOURIER ANALYSIS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HYDROGEN BOND; IN VITRO STUDY; MAXIMUM STRAIN; PH; RELATIVE DENSITY; SUSTAINED DRUG RELEASE; TENSILE STRENGTH; THERMOGRAVIMETRY; THERMOSTABILITY; VISCOSITY; YOUNG MODULUS; 3T3 CELL LINE; ANIMAL; CHEMISTRY; DRUG EFFECTS; DRUG ELUTING STENT; DRUG FORMULATION; DRUG RELEASE; INFRARED SPECTROSCOPY; MOUSE; SCANNING ELECTRON MICROSCOPY; ULTRASTRUCTURE;

ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; CALORIMETRY, DIFFERENTIAL SCANNING; CELL PROLIFERATION; DRUG COMPOUNDING; DRUG LIBERATION; DRUG-ELUTING STENTS; DUODENUM; HYDROGEN-ION CONCENTRATION; MICE; MICROSCOPY, ELECTRON, SCANNING; NANOFIBERS; NIH 3T3 CELLS; PACLITAXEL; POLYMETHACRYLIC ACIDS; POLYURETHANES; SPECTROSCOPY, FOURIER TRANSFORM INFRARED;

EID: 84910647136     PISSN: 03785173     EISSN: 18733476     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2014.10.057     Document Type: Article

References (27)

1. Blumenschein, G., Sandler, A., O'Rourke, T., Eschenberg, M., Sun, Y., Gladish, G., Salgia, R., Alden, C., Herbst, R.S., Reckamp, K., 2006. Safety and pharmacokinetics (PK) of AMG 706, panitumumab, and carboplatin/paclitaxel (CP) for the treatment of patients (pts) with advanced non-small cell lung cancer (NSCLC). J. Clin. Oncol. 24, 393s-394s.
2. Dressman, J.B., Berardi, R.R., Dermentzoglou, L.C., Russell, T.L., Schmaltz, S.P., Barnett, J.L., Jarvenpaa, K.M., 1990. Upper gastrointestinal (Gi) Ph in young, healthy-men and women. Pharm. Res. 7, 756-761.
3. Elgindy, N., Samy, W., 2009. Evaluation of the mechanical properties and drug release of cross-linked Eudragit films containing metronidazole. Int. J. Pharm. 376, 1-6.
4. Greiner, A., Wendorff, J.H., 2007. Electrospinning: a fascinating method for the preparation of ultrathin fibres. Angew. Chem. Int. Ed. 46, 5670-5703.
5. Groothuis, A., Seifert, P., Spognardi, A., Donaghy, D., Rogers, C., 2006. Dissociating DES safety and efficacy: endothelial regrowth and drug effect after abluminal or circumferential paclitaxel delivery from a bioerodable polymer in porcine coronaries. Am. J. Cardiol. 98, 134m-135m.
6. Huang, Z.M., Zhang, Y.Z., Kotaki, M., Ramakrishna, S., 2003. A review on polymer nanofibers by electrospinning and their applications in nanocomposites. Compos. Sci. Technol. 63, 2223-2253.
7. Ishan Patel, T.A., Srivastav, B.S., 2013. Eudragit a versatile polymer: a review. Int. J. Chem. Pharm. Sci. vol. 1, 305-311.
8. Jang, S.I., Kim, J.H., Kim, M., Yang, S., Jo, E.A., Lee, J.W., Na, K., Kim, J.M., Jeong, S., Lee, D.H., Lee, D.K., 2012. Porcine feasibility and safety study of a new paclitaxel-eluting biliary stent with a pluronic-containing membrane. Endoscopy 44, 825-831.
9. Jeong, S., Lee, D.H., Maeng, J.H., Hong, S.S., Park, I.S., Jeon, Y.S., Park, S.S., Kang, S.G., Lee, J.I., Lee, J.W., Kwon, K.S., Kim, H.G., Shin, Y.W., Kim, Y.S., 2007. Antitumor activity of paclitaxel-eluting polyurethane membrane as a stent-covering material: in vivo preliminary results in animal model. Gastroenterology 132, A204-A205.
10. Kang, S.G., Lee, S.C., Choi, S.H., Park, S., Jeong, S., Lee, D.H., Kim, M., 2010. Paclitaxel-polyurethane film for anti-cancer drug delivery: film characterization and preliminary in vivo study. Macromol. Res. 18, 680-685.
11. Karthikeyan, K., Guhathakarta, S., Rajaram, R., Korrapati, P.S., 2012. Electrospun zein/eudragit nanofibers based dual drug delivery system for the simultaneous delivery of aceclofenac and pantoprazole. Int. J. Pharm. 438, 117-122.
12. Khan, M.Z.I., Prebeg, Z., Kurjakovic, N., 1999. A pH-dependent colon targeted oral drug delivery system using methacrylic acid copolymers. I. Manipulation of drug release using Eudragit® L100-55 and Eudragit® S100 combinations. J. Control. Release 58, 215-222.
13. Khan, M.Z.I., Stedul, H.P., Kurjakovic, N., 2000. A pH-dependent colon-targeted oral drug delivery system using methacrylic acid copolymers. II. Manipulation of drug release using Eudragit® L100 and Eudragit S100 combinations. Drug Dev. Ind. Pharm. 26, 549-554.
14. Kiran Kumar, V., Namratha Rani, N.A.r., Seshagiri Rao, J.V.L.N., Satyaranrana, T., 2009. Estimation of paclitaxel in parenterals by RP-HPLC. Asian J. Res. Chem. 2, 90-92.
15. Lee, S.S., Shin, J.H., Han, J.M., Cho, C.H., Kim, M.H., Lee, S.K., Kim, J.H., Kim, K.R., Shin, K.M., Won, Y.H., Song, H.Y., 2009. Histologic influence of paclitaxel-eluting covered metallic stents in a canine biliary model. Gastrointest. Endosc. 69, 1140-1147.
16. Liu, H.J., Zhang, X.Y., Suwardie, H., Wang, P., Gogos, C.G., 2012. Miscibility studies of indomethacin and Eudragit® E PO by thermal, rheological, and spectroscopic analysis. J. Pharm. Sci. (U. S. A) 101, 2204-2212.
17. Persano, L., Camposeo, A., Tekmen, C., Pisignano, D., 2013. Industrial upscaling of electrospinning and applications of polymer nanofibers: a review. Macromol. Mater. Eng. 298, 504-520.
18. Qi, S., Gryczke, A., Belton, P., Craig, D.Q.M., 2008. Characterisationof solid dispersions of paracetamol and EUDRAGIT® E prepared by hot-melt extrusion using thermal, microthermal and spectroscopic analysis. Int. J. Pharm. 354, 158-167.
19. Qing, G.Y., Li, M.M., Deng, L.J., Lv, Z.Y., Ding, P., Sun, T.L., 2013. Smart drug release systems based on stimuli-responsive polymers. Mini. Rev. Med. Chem. 13, 1369-1380.
20. Schiffman, J.D., Schauer, C.L., 2008. A review: electrospinning of biopolymer nanofibers and their applications. Polym. Rev. 48, 317-352.
21. Shaikh, M., Kichenadasse, G., Choudhury, N.R., Butler, R., Garg, S., 2013. Non-vascular drug eluting stents as localized controlled drug delivery platform: preclinical and clinical experience. J. Control. Release 172, 105-117.
22. Shen, X.X., Yu, D.G., Zhu, L.M., Branford-White, C., White, K., Chatterton, N.P., 2011. Electrospun diclofenac sodium loaded Eudragit® L 100-55 nanofibers for colon-targeted drug delivery. Int. J. Pharm. 408, 200-207.
23. Shim, M.S., Kwon, Y.J., 2012. Stimuli-responsive polymers and nanomaterials for gene delivery and imaging applications. Adv. Drug Deliv. Rev. 64, 1046-1058.
24. Song, T.J., Lee, S.S., Yun, S.C., Park, D.H., Seo, D.W., Lee, S.K., Kim, M.H., 2011. Paclitaxel-eluting covered metal stents versus covered metal stents for distal malignant biliary obstruction: a prospective comparative pilot study. Gastrointest. Endosc. 73, 727-733.
25. Terao, T., Matsuda, K., Shouji, H., 2001. Improvement in site-specific intestinal absorption of furosemide by Eudragit L100-55. J. Pharm. Pharmacol. 53, 433-440.
26. Tiwari, S.B., Amiji, M.M., 2006. Improved oral delivery of paclitaxel following administration in nanoemulsion formulations. J. Nanosci. Nanotechnol. 6, 3215-3221.
27. Vilar, G., Tulla-Puche, J., Albericio, F., 2012. Polymers and drug delivery systems. Curr. Drug Deliv. 9, 367-394.